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Abstract. 
 
The molecular motor kinesin is an ATPase that 
mediates plus end-directed transport of organelles along 
microtubules. Although the biochemical properties of 
kinesin are extensively studied, conclusive data on regu-
lation of kinesin-mediated transport are largely lacking. 
Previously, we showed that the proinflammatory cytokine 
tumor necrosis factor induces perinuclear clustering of 
mitochondria. Here, we show that tumor necrosis factor 
impairs kinesin motor activity and hyperphosphorylates 
kinesin light chain through activation of two putative 
kinesin light chain kinases. Inactivation of kinesin, hyper-
phosphorylation of kinesin light chain, and perinuclear 
clustering of mitochondria exhibit the same p38 mitogen-
activated kinase dependence, indicating their functional 
relationship. These data provide evidence for direct regu-
lation of kinesin-mediated organelle transport by extra-
cellular stimuli via cytokine receptor signaling pathways.
Key words: microtubule • organelle • okadaic acid • 
mitogen-activated protein kinase • phosphorylation 
 
Introduction
 
Conventional kinesin (KIF5), originally discovered in 1985
(Brady, 1985; Vale et al., 1985), is a tetramer of two kine-
sin heavy chains (KHCs)
 
1
 
 and two kinesin light chains
(KLCs). Three domains compose KHC: an NH
 
2
 
-terminal
motor domain containing the ATPase activity and the mi-
crotubule (MT)-binding sites (Yang et al., 1989); a central
 
a
 
-helical coiled-coil involved in dimerization (de Cuevas
et al., 1992); and a COOH-terminal tail, which binds KLC
(Diefenbach et al., 1998). The KHC-tail:KLC complex ap-
pears to be a crucial regulatory target, involved in interac-
tion with cargo (Brady and Pfister, 1991; Stenoien and
Brady, 1997; Khodjakov et al., 1998) and controlling the
motor activity of the motor protein (Hackney et al., 1991;
Verhey et al., 1998; Coy et al., 1999; Friedman and Vale,
1999; Rahman et al., 1999; Stock et al., 1999).
KHC and KLC are reversibly phosphorylated on serine
residues in vivo, suggesting that phosphorylation is in-
volved in kinesin regulation. Indeed, KHC of membrane-
bound, presumably active kinesin is hyperphosphorylated
in vivo (Lee and Hollenbeck, 1995) and kinesin phosphor-
ylation by protein kinase A (PKA) in vitro increased kine-
sin ATPase activity and thus may stimulate transport
(Matthies et al., 1993). However, phosphorylation by PKA
also reduced binding of kinesin to synaptic vesicles sug-
gesting to the contrary decreased vesicle transport (Sato-
Yoshitake et al., 1992). In a different approach, using oka-
daic acid (OA) to drive hyperphosphorylation of kinesin
in cytosolic extracts, McIlvain et al. (1994) showed hyper-
phosphorylation of three components of the kinesin com-
plex, but not of KHC in correlation with increased kinesin
activity in vitro. One of these associated proteins was re-
cently identified as KLC, and hyperphosphorylation of
this KLC isoform was sufficient to increase kinesin activity
in vitro (Lindesmith et al., 1997). Similarly increased
vesicle motility was observed in OA-treated CV-1 cells
(Hamm-Alvarez et al., 1993). However, in these cells no
hyperphosphorylation of kinesin-associated proteins could
be demonstrated, suggesting an indirect effect of OA on
kinesin activity (McIlvain et al., 1994). Also, in melano-
phores, melanocyte stimulating hormone-induced disper-
sion of melanosomes by kinesin-II was dependent on PKA
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activity, but again was not accompanied by changes in ki-
nesin-II phosphorylation (Reilein et al., 1998). Taken to-
gether, these studies put forward KLC as a target of phos-
phorylation-dependent regulation of kinesin, although the
lack of conclusive data linking in vitro kinesin phosphory-
lation and kinesin activity in vivo makes it difficult to as-
sess the relevance of this regulatory phosphorylation in in-
tact cells.
Previously, we showed that stimulation of sensitive cells
with the proinflammatory cytokine tumor necrosis factor
(TNF) induces abnormal, perinuclear clustering of mito-
chondria from an evenly spread distribution throughout
the cytoplasm, the mitochondria withdraw from the cell
periphery and aggregate in an unipolar, perinuclear clus-
ter. This clustering of mitochondria was MT-dependent
and mimicked by SUK4 mAb-mediated immunoinhibition
of conventional kinesin, suggesting that TNF-induced mi-
tochondrial clustering is caused by impaired kinesin-medi-
ated transport of mitochondria (De Vos et al., 1998).
Here, we show that TNF receptor-I induces activation of
kinase pathways, resulting in hyperphosphorylation of
KLC and inhibition of kinesin activity. These results pro-
vide a molecular basis for the previously reported perinu-
clear clustering of mitochondria.
 
Materials and Methods
 
Materials
 
Unless otherwise stated, all chemicals used in this study were purchased
from Sigma-Aldrich.
 
Cell Culture and Stimulation
 
L929 cells were cultured as described (De Vos et al., 1998) and were typi-
cally stimulated for 1 h with 1,000 IU/ml murine TNF (specific activity of
1.98 IU/mg of protein, purified in our laboratory). Where needed,
SB203580 (10 
 
m
 
M; Alexis Biochemicals) was added to the cells 2 h before
stimulation with TNF.
 
Analysis of Mitochondrial Distribution
 
The distribution of the mitochondria was analyzed with a Zeiss LSM 410
microscope as described (De Vos et al., 1998). Rhodamine 123 (Molecular
Probes) was excited at 488 nm and detected with a 525–540 nm band pass
filter. At regular times after stimulation, CLSM images from four ran-
domly chosen microscopic fields, each containing 
 
z
 
60 cells, were re-
corded. Clustering of mitochondria was represented as the mean of the
frequency of the clustered phenotype of four fields (number of viable cells
with clustered mitochondrial phenotype/total number of viable cells). Dig-
ital processing and color adjustment of the images was done using Corel
Photo-Paint software.
 
Preparation of Total Cell Lysate
and Microtubule-associated Protein
(MAP)-depleted Cytosol
 
Total Cell Lysate. 
 
Suspension cultures of L929 cells were harvested and
washed three times with ice-cold TBS to remove culture medium. The cell
pellet was resuspended in 0.9 vol of lysis buffer (35 mM K-Pipes, 5 mM
MgSO
 
4
 
, 5 mM EGTA, 0.5 mM EDTA, 1 mM DTT, pH 7.4; PMEE) sup-
plemented with phosphatase inhibitors (NaF, 
 
b
 
-glycerophosphate, and
vandadate), protease inhibitors (Complete™ EDTA-free; Boehringer),
and 1% CHAPS, and left on a rotor for 10 min at 4
 
8
 
C. The lysate was clar-
ified by centrifugation at 20,800 
 
g
 
 for 15 min at 4
 
8
 
C. The protein concen-
tration was determined by the Bradford method.
 
Undepleted Cytosol (In Vitro Kinase Assay). 
 
Suspension cultures of
L929 cells were harvested and washed three times with ice-cold TBS to re-
 
move culture medium. The cell pellet was resuspended in PMEE lysis
buffer supplemented with 0.03% digitonin (Merck), protease inhibitors,
and phosphatase inhibitors, and shaken for 3 min at room temperature.
The cytosol was recovered by centrifugation (20,800 
 
g
 
, 15 min, 4
 
8
 
C) and
the protein concentration was estimated with the Bradford method.
 
MAP-depleted Cytosol (Motility Assays). 
 
Adherent L929 cell cultures
were harvested by trypsinization and washed three times with cold PBS.
The remainder of the procedure was performed at 4
 
8
 
C. The cell pellet was
resuspended in 0.9 vol PMEE lysis buffer supplemented with 0.25 mM su-
crose and protease inhibitors (PMEES), followed by douncing (200
strokes). Unbroken cells and nuclei were removed by centrifugation at
3,000 
 
g
 
 for 10 min followed by centrifugation at 200,000 
 
g
 
 for 30 min to ob-
tain the cytosolic fraction. Thereafter, the cytosol was MAP-depleted by
MT affinity. Unlabeled MTs were polymerized from 50 
 
m
 
l purified tubulin
(22 mg/ml) by 30 min incubation at 37
 
8
 
C in the presence of 1 mM GTP
and 15 
 
m
 
l glycerol. After incubation, the MT-containing solution was ad-
justed to 200 
 
m
 
l with BRB80-Taxol buffer (80 mM K-Pipes, 1 mM GTP,
1 mM MgCl
 
2
 
, pH 6.8, and 10 
 
m
 
M Taxol; Molecular Probes). Subsequently,
the MTs were spun at 28 psi in an airfuge (Beckman Coulter) for 5 min
and resuspended in 50 
 
m
 
l BRB80-Taxol. For MAP depletion, 50 
 
m
 
l of un-
labeled Taxol-stabilized MTs was added to cytosol prepared from 8–10 
 
3
 
10
 
7
 
 L929 cells that was adjusted to 4 mM Mg-ATP to prevent binding of
kinesin to the MTs. This cytosol-MT mix was incubated for 15 min at
37
 
8
 
C, followed by centrifugation (160,000 
 
g
 
, 20 min, 20
 
8
 
C) to remove the
MTs and MT-associated MAPs. The MAP-depleted cytosol was kept on
ice until use or snap-frozen in liquid nitrogen.
 
Isolation of Mitochondria
 
In Vitro Motility.  
 
Mitochondria of adherent L929 cell cultures were la-
beled with Mitotracker GreenFM (1 
 
m
 
M; Molecular Probes) for 30 min
under culture conditions. The cells were harvested by trypsinization,
transferred to 4
 
8
 
C, and washed twice with ice-cold PBS and once with ice-
cold mitochondria lysis buffer (10 mM Hepes, 220 mM mannitol, 70 mM
sucrose, 1 mM EDTA, and protease inhibitors, pH 7.4; MB). The cell pel-
let was resuspended in 0.9 vol of MB buffer and homogenized with a tis-
sue grinder (pestle 19, Kontes, 100 strokes). Unbroken cells and nuclei
were removed by centrifugation (3,000 
 
g
 
, 10 min 4
 
8
 
C), followed by pellet-
ing of the mitochondria (13,000 
 
g
 
, 15 min, 4
 
8
 
C). The mitochondrial pellet
was resuspended in MB buffer and kept on ice. Mitochondria were freshly
isolated before each experiment and used within 3 h after isolation.
 
Western Blot Analysis.  
 
Adherent L929 cell cultures were harvested by
trypsinization, transferred to 4
 
8
 
C, and washed twice with ice-cold PBS and
once with ice-cold MB buffer. The cell pellet was resuspended in 0.9 vol of
MB buffer and homogenized with a tissue grinder (pestle 19, Kontes, 100
strokes). Unbroken cells and nuclei were removed by centrifugation
(3,000 
 
g
 
, 10 min, 4
 
8
 
C). A crude mitochondrial pellet was obtained by cen-
trifugation for 15 min at 13,000 
 
g
 
. Resuspended mitochondria were trans-
ferred on top of a discontinuous sucrose gradient (1.6 M sucrose, 0.1%
BSA, 1 mM EDTA, 10 mM KH
 
2
 
PO
 
4
 
, pH 7.4; 1.2 M sucrose, 0.1% BSA,
1 mM EDTA, 10 mM KH
 
2
 
PO
 
4
 
, pH 7.4), and centrifuged at 42,000 rmp in
a SW50.1 rotor (Beckman Coulter) for 1.5 h at 4
 
8
 
C. Mitochondria were re-
covered at the 1.6 M/1.2 M interface, supplemented with 9 vol MB, and
subsequently pelleted by centrifugation at 100,000 
 
g
 
 in a 50Ti rotor (Beck-
man Coulter). The mitochondrial pellet was subsequently lysed in PMEE
supplemented with 1% NP-40. Mitochondrial proteins were separated on
7.5% SDS-PAGE.
 
Immunoprecipitation
 
2 mg total cell lysate was precleared by addition of 50 
 
m
 
l 50% protein
G–Sepharose (Amersham Pharmacia Biotech) in PMEE and rotation for
2 h at 4
 
8
 
C. 15 
 
m
 
g antibody (Ab) was added and the lysate–Ab mix was ro-
tated for 2 h at 4
 
8
 
C before addition of 25 
 
m
 
l 50% protein G–Sepharose.
After overnight rotation at 4
 
8
 
C, the immune complex was washed five
times with PMEE lysis buffer without CHAPS. KHC and KLC were im-
munoprecipitated with SUK4 mAb (Ingold et al., 1988) and antipan-KLC
(pAb against squid KLC, 35.1; BAbCO) Ab, respectively; mouse anti–
hamster IgG (BD PharMingen) was used as control Ab.
 
In Vitro Kinase Assay
 
The kinesin immune complex was mixed with 10 
 
m
 
Ci 
 
g
 
[P
 
32
 
]ATP and,
where needed, with cytosol (1–1.5 mg) in 250 
 
m
 
l. The reaction mix was in-
cubated for 5 min at 37
 
8
 
C and the reaction was stopped by transfer to 4
 
8
 
C
and extensive washing of the immune complex with lysis buffer. The pellet
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was resuspended in SDS-loading buffer (New England Biolabs, Inc.) con-
taining 
 
b
 
-mercaptoethanol, boiled, and separated on 12.5% SDS-PAGE.
The gel was dried on paper and the incorporation of P
 
32
 
 was analyzed with
an FX PhosphorImager (BioRad).
 
In Vitro Motility
 
MT Gliding Assay. 
 
Glass coverslips (22 
 
3
 
 22 mm; No. 1 Gold Seal, Clay
Adams) were sealed onto a glass slide (KTH 360; Propper Ltd.) using two
lines of Apezion M grease (Roth) to make 10 
 
m
 
l perfusion chambers. 10 
 
m
 
l
of 5 
 
m
 
g/
 
m
 
l MAP-depleted cytosol was perfused into the chamber and al-
lowed to bind for 5 min at room temperature, followed by perfusion of 3
mg/ml casein. Rhodamine-labeled MTs (Hyman, 1991) were perfused into
the chamber and allowed to bind 1 min before addition of motility buffer
(4 mM ATP, 75 mM KCl in PMEE).
 
Mitochondrial Motility. 
 
Rhodamine-labeled, polarity-marked MTs were
perfused into the chamber and allowed to bind for 5 min. Unbound MTs
were washed away with 3 mg/ml casein, followed by blocking the chamber
with casein for 1 min. Casein was washed away with PMEES and reaction
mix containing 8 
 
m
 
l MAP-depleted cytosol (5 
 
m
 
g/
 
m
 
l), 3 
 
m
 
l isolated mito-
chondria, and 1 
 
m
 
l ATP/KCl stock solution (10 mM ATP, 750 mM KCl in
PMEE) was perfused into the chamber.
 
Data Acquisition. 
 
The chambers were observed with a COHU CCD
camera on a Zeiss Axiovert 10 at room temperature with a 63
 
3
 
 Plan-
APOCHROMAT lens using NIH-image software and a rhodamine (MTs)
or fluorescein (mitochondria) filter set. In the gliding assay, MTs were ob-
served for 4–5 min in 2- or 4-s time intervals. Mitochondria were observed
for 2–4 min with 2- or 4-s time intervals. Movement of mitochondria was
defined as linear motions over at least three time intervals. Velocity was
determined using Retrac software written by Dr. N. Carter (http://
mc11.mcri.ac.uk/Retrac/RT-home.html).
 
Two-dimensional Gel Electrophoresis (2-DE)
 
For 2-DE, 500 
 
m
 
g protein was isoelectrofocused on 18-cm immobilized
PH-gradient strips (Amersham Pharmacia Biotech) ranging from pH 3 to
pH 10, followed by SDS-PAGE on 6–16% gradient gels.
 
Western Blot Analysis
 
Proteins were transferred to PVDF membranes (Amersham Pharmacia
Biotech) by wet electroblotting and processed for ECL (Amersham Phar-
macia Biotech) detection. KHC was detected using SUK4 mAb (1 
 
m
 
g/ml),
or anti-KIF5B Ab, followed by HRP-conjugated anti-mouse Ig or HRP-
conjugated anti-rabbit Ig Ab (1/2,000; Amersham Pharmacia Biotech), re-
spectively. KLC was detected with antipan-KLC Ab (1/4,000) and HRP-
conjugated anti-rabbit Ig Ab. ECL detection was performed according to
the manufacturer’s protocol. In the case of 2-DE blots, KHC was analyzed
on the same blots used earlier for ECL detection of KLC by NBT/BCIP
detection with SUK4 mAb (1 
 
m
 
g/ml) and AP-conjugated anti-mouse Ig
(Sigma-Aldrich).
 
Syringe Loading
 
L929 cells were syringe-loaded as described previously (De Vos et al., 1998).
 
Results
 
TNF Signaling Inhibits Conventional Kinesin
 
Previously, we reported that TNF receptor I signal-
ing causes abnormal, perinuclear clustering of mitochon-
dria, indicating inhibition of kinesin-mediated, plus end-
directed transport of mitochondria (De Vos et al., 1998).
To directly assess the influence of TNF signaling on molec-
ular motor-mediated transport, we analyzed in vitro the
activity of molecular motors present in MAP-depleted cy-
tosolic extracts of L929 cells treated with TNF for 1 h. Mo-
tor activity was assayed by MT gliding mediated by immo-
bilized cytosolic proteins and by motility of mitochondria
on immobilized MTs in the presence of cytosol. We choose
for MAP-depleted cytosol to prevent inhibition of motility
Figure 1. Inhibition of kinesin motor activity in TNF-treated
L929 cells. A and B, MAP-depleted cytosol was prepared from
untreated (CTRL) and TNF-treated (TNF) L929 cells and the
level of kinesin motor activity in these preparations was tested in an
MT-gliding assay (A) and a mitochondrial motility assay (B). In
the MT-gliding assay, coverslips were coated with the respective
cytosols, and rhodamine-labeled MTs were added together with
ATP. The number of gliding MTs was determined relative to
the total number of MTs present in a microscopic field. To iden-
tify the active molecular motor present in the untreated cytosol,
SUK4 mAb was added (SUK4). Data shown are the mean and
SEM calculated from at least ten different microscopic fields
and are representative of a minimum of three independent experi-
ments. The values of control and TNF samples were significantly
different as determined using a one-tailed heteroscedastic t test
(P , 0.01). In the mitochondrial motility assay, MTs were ab-
sorbed on coverslips and a reaction mix containing mitotracker-
labeled mitochondria, ATP, and cytosol from untreated or TNF-
treated L929 cells was added. The number of moving mitochondria
per microscopic field was determined. The results shown repre-
sent the mean and SEM of 25 fields and are representative of three
independent experiments (P , 0.01). C, The merged images of
mitochondrial motility were generated by overlaying stacks of
photos of mitochondria (green) collected at 4-s intervals with a
photo of the immobilized MTs (red). The starting position of the
mitochondria is indicated by the open arrow, the end position by
the filled arrow. The plus end (1) and the minus end (–) of the
MTs are indicated. D, The KHC and KLC content of the respec-
tive cytosols used in the gliding and mitochondrial motility assays
was verified by Western blot with SUK4 mAb and antipan-KLC
Ab, respectively. E, Mitochondria were purified from untreated
(CTRL) and TNF-treated (TNF) L929 cells and the amount of
copurifying KHC was determined by Western blot analysis using
anti-KIF5B Ab.
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by MT-bound MAPs (Heins et al., 1991; Lopez and
Sheetz, 1993, 1995; Bulinski et al., 1997; Ebneth et al.,
1998). Cytosol of untreated cells clearly contained active
molecular motors capable of driving MT-gliding and mito-
chondrial motility in vitro (Fig. 1, A and B).
In the MT-gliding assay, MTs were typically observed
for 4–5 min with 2- or 4-s time intervals. Use of polarity-
marked MTs (Hyman, 1991) in the gliding assay allowed
identification of the active motors in the untreated, MAP-
depleted cytosol as plus end-directed (
 
.
 
95%), excluding
the minus end-directed motors from the measurements.
The average gliding velocity was 1.2 
 
6
 
 0.03 
 
m
 
m/s. Further-
more, the observed plus end-directed activity could be
nearly completely inhibited by addition of SUK4 mAb, a
well-characterized mAb directed against the motor do-
main of conventional kinesin (Ingold et al., 1988), identify-
ing the motor activity present in our lysates as conven-
tional kinesin (Fig. 1 A).
In the mitochondria motility assay, mitochondria were
observed for 2–4 min with 2- or 4-s time intervals. Move-
ment was defined as linear motion along a MT over at
least three time intervals. Typically, 
 
z
 
2% of the added mi-
tochondria moved along the immobilized, polarity-marked
MTs. Similar to the MT-gliding assay, 96% of the ob-
served movements were plus end-directed. Mitochondria
moved over an average distance of 4.92 
 
6
 
 0.69 
 
m
 
m, with an
average velocity of 0.59 
 
6 
 
0.08 
 
m
 
m/s. Two typical exam-
ples are shown in Fig. 1 C.
When TNF-treated cytosol was applied, MT-gliding
and mitochondrial motility were drastically reduced in
comparison to the untreated control (Fig. 1, A and B).
Western blot analysis showed that decreased MT-gliding
and mitochondrial motility were not caused by reduced
amounts of KHC or KLC in the cytosol preparations of
TNF-treated cells (Fig. 1 D). Furthermore, no notable dif-
ference in the number of bound MTs between untreated
and TNF-treated cytosol was observed in the gliding assay
(data not shown). Diminished kinesin levels and/or im-
paired binding of kinesin to MTs can therefore be ex-
cluded as cause(s) of the lower number of gliding MTs in
the TNF-treated condition. Also, the lower number of mi-
tochondrial movements supported by TNF-treated cytosol
could not be attributed to detachment of the motors from
the organelles as the number of MT-bound mitochondria
using TNF-treated cytosol did not significantly differ from
the control (data not shown), and conventional kinesin
copurified with mitochondria nearly equally in untreated
and TNF-treated cells (Fig. 1 E). Therefore, we conclude
that inactivation of kinesin motor activity, but not its MT-
or cargo-binding activity, is responsible for inhibition of plus
end-directed transport of mitochondria in TNF-treated
L929 cells.
 
TNF Signaling Induces Hyperphosphorylation of KLC
 
TNF is known to activate several kinases (including the
mitogen-activated protein kinase [MAPK] family), leading
to phosphorylation of various substrate molecules (Van
Lint et al., 1992; Beyaert et al., 1996). As the MT-gliding
and mitochondrial motility assay suggested a direct modu-
lation of kinesin motor activity, we decided to investigate
the phosphorylation state of conventional kinesin in TNF-
stimulated cells. Lee and Hollenbeck (1995) showed that
both KHC and KLC exist in several isoelectric forms in
cultured cells and that these represent phosphoisoforms.
Accordingly, we compared the relative abundance of these
phosphoisoforms in untreated versus TNF-treated L929
cells by 2-DE and Western blot with anti-KHC mAb
SUK4 or antipan-KLC Ab. In agreement with literature,
we found that in L929 cells KHC and KLC exist in several
isoforms, differing in both isoelectric point and molecular
weight. Both KLC isoforms detected were named KLC1
and KLC2, according to Rahman et al. (1998). In TNF-
treated cells, these isoforms showed a shift to more acidic
isoelectric points (higher phosphorylation), whereas the
isoelectric point distribution of KHC isoforms remained
unchanged (Fig. 2, A and B). Thus, TNF signaling directly
targets kinesin and, more particularly, KLC.
To verify if the increase in KLC phosphorylation in
TNF-treated cells is the result of augmented kinase activ-
ity, we set up an in vitro kinase assay in which immunopre-
cipitated kinesin was used as substrate. To avoid interfer-
ence of KLC-bound Ab with phosphorylation, KLC was
coimmunoprecipitated with KHC using the KHC-specific
SUK4 mAb rather than directly immunoprecipitated by
Figure 2. TNF induces hyperphosphorylation of KLC. A and B,
Total lysates of untreated (CTRL) and TNF-treated (TNF) cells
were separated by 2-DE (IP and MW) and transferred to PVDF
membranes for Western blot analysis. KLC (A) and KHC (B)
were revealed with antipan-KLC Ab and SUK4 mAb respec-
tively. The filled arrow indicates isoelectric isoforms that disap-
pear upon TNF-treatment. Open arrows indicate TNF-induced
isoforms. C, KLC, coimmunoprecipitated with KHC (Immunop.)
from untreated (CTRL) or TNF-treated (TNF) cells was incu-
bated with g[P32]-ATP alone (left). Alternatively, KLC coimmu-
noprecipitated with KHC from untreated L929 cells was supple-
mented with cytosol of untreated or TNF-treated cells (right).
After completion of the in vitro kinase assay, the immune com-
plex was separated by SDS-PAGE. P32 incorporation was visual-
ized by PhosphorImager.
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antipan-KLC Ab. Incubation of kinesin immunoprecipi-
tates from untreated cells with 
 
g
 
[P
 
32
 
]ATP in the absence
of cytosol produced a background phosphorylation of
KLC2 (Fig. 2 C, left), suggesting that KLC2 is phosphory-
lated by a constitutive kinesin-associated kinase. This is in
agreement with Lindesmith et al. (1997) who also found
that a KLC-isoform is directly phosphorylated by a kine-
sin-associated KLC kinase. KLC2 phosphorylation was
clearly enhanced in coimmunoprecipitates from TNF-
stimulated cells indicating increased activity of a puta-
tive kinesin-associated KLC2 kinase upon TNF-treatment
(Fig. 2 C, left). Addition of cytosol of untreated cells pro-
duced additional phosphorylation of KLC1, indicating that
KLC1 is phosphorylated by a specific cytosolic kinase dis-
tinct from the kinesin-associated KLC2 kinase. Cytosol of
TNF-treated cells further enhanced phosphorylation of
both KLCs, but especially of KLC1 (Fig. 2 C, right). Thus,
both results from the in vitro kinase assay indicate that the
hyperphosphorylation of KLC1 and KLC2 observed in
TNF-treated cells is caused by enhanced kinase activity.
Remarkably, the in vitro assay did not reveal KHC
phosphorylation (data not shown). This negative result,
apparently in contradiction with the situation in L929 cells
where several isoelectric isoforms of KHC were present,
was not caused by the attached SUK4 mAb as in a re-
versed approach, using antipan-KLC Ab to coimmunopre-
cipitate KHC; also, no KHC phosphorylation was detected
(data not shown). Apparently, KHC is already fully phos-
phorylated when immunoprecipitated and therefore no la-
beled phosphate is incorporated during the in vitro kinase
assay.
We conclude that stimulation of L929 cells with TNF
initiates a cytoplasmic signaling pathway leading to en-
hanced phosphorylation of KLC, but not KHC. KLC hy-
perphosphorylation apparently is caused by activation of
two distinct KLC kinases, one cytosolic and the other ki-
nesin-associated, which hyperphosphorylate KLC1 and
KLC2, respectively.
 
Hyperphosphorylation of KLC Correlates with 
Inactivation of Kinesin and Perinuclear Clustering
of Mitochondria
 
It has been shown that TNF activates PKA and the MAPK
family (Zhang et al., 1988; Van Lint et al., 1992; Beyaert et
al., 1996; Boone et al., 1998). While pharmacological stud-
ies showed that PKA does not phosphorylate kinesin in
vivo (Hollenbeck, 1993), a recent report showed that the
mixed lineage kinases, MLK2 and MLK3, associate with
members of the KIF3 subfamily (Nagata et al., 1998), sug-
gesting that MAPK may be involved in phosphorylation of
kinesin. Overexpression of MLK2 activates, among others
p38MAPK, which was shown to participate in TNF-signal-
ing in L929 cells (Beyaert et al., 1996). Therefore we ana-
lyzed the role of p38MAPK in TNF-induced inhibition of
conventional kinesin and KLC hyperphosphorylation.
2-DE analysis of KLC-phosphoisoforms from SB203580/
TNF-cotreated L929 cells showed that application of SB-
203580, a specific inhibitor of p38MAPK (Cuenda et al.,
1995), inhibited the TNF-induced shift toward more acidic
isoforms of KLC1 and KLC2 in vivo (Fig. 3 A). In the case
of KLC2, SB203580 not only inhibited the TNF-mediated
acidic shift, indicative for hyperphosphorylation, but also
induced less acidic isoforms as compared with the control
only treated with TNF, suggesting that p38MAPK is also
involved in the constitutive activation of KLC2 kinase in
TNF-treated cells. In vitro kinase assays confirmed these
observations; KLC2 phosphorylation was no longer in-
creased when conventional kinesin, immunoprecipitated
from SB203580/TNF-cotreated cells, was incubated with
 
g
 
[P
 
32
 
]ATP (Fig. 3 B, left). Furthermore, the increment of
KLC1 phosphorylation and, to a lesser extent, of KLC2 af-
ter incubation with cytosol from TNF-treated cells was
no longer observed when cytosol from SB203580/TNF-
cotreated cells was used instead (Fig. 3 B, right). Both re-
sults with cultured cells and in vitro results therefore indi-
cate that p38MAPK is part of the TNF-induced signaling
pathway leading to hyperphosphorylation of KLC1 and
KLC2. In addition the lack of effect of SB203580 on the
basal level of KLC phosphorylation in the in vitro kinase
assay indicates that the putative TNF-induced KLC1 and
KLC2 kinase activities are distinct from the kinase activi-
ties responsible for basal KLC phosphorylation. It is note-
worthy that SB203580, per se, induced higher phosphory-
lation of KLC2 in L929 cells when compared with the
untreated control shown in Fig. 2. However, this increase
in phosphorylation was not observed in the in vitro kinase
assay (Fig. 3 B). Therefore, it is likely this increase is not
the result of enhanced kinase activity as in the case of
TNF-induced KLC2 hyperphosphorylation, but might be
caused by decreased phosphatase activity that is not de-
tected in the in vitro kinase assay.
The inhibitory activity of the p38MAPK inhibitor,
SB203580, on TNF-induced KLC phosphorylation pro-
vided us with a tool to investigate the relationship between
TNF-induced KLC hyperphosphorylation and inhibition
of kinesin activity. Kinesin activity in cytosol of SB203580/
TNF-cotreated cells was directly measured with the MT-
gliding and mitochondrial motility assays as described
Figure 3. The p38MAPK inhibitor SB203580 inhibits TNF-induced
KLC hyperphosphorylation. A, Total lysates of SB203580-
treated (SB), and SB203580/TNF-cotreated (SB/TNF) L929 cells
were separated by 2-DE, transferred to PVDF membranes, and
were analyzed by Western blot with antipan-KLC Ab. B, KLC,
coimmunoprecipitated with SUK4 mAb (Immunop.) from un-
treated (CTRL), SB203580-treated (SB), TNF-treated (TNF), or
SB203580/TNF-cotreated (SB/TNF) L929 cells incubated with
g[P32]-ATP alone (left) or supplemented with cytosol of the re-
spective cell populations (right). Next, the immune complex was
separated by SDS-PAGE and P32 incorporation was visualized by
PhosphorImager.
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above. In these assays, SB203580 neutralized the TNF ef-
fect. Thus, SB203580 restored MT-gliding and mitochon-
drial motility to control levels without affecting the amount
of kinesin in the cytosol extracts nor MT-binding and or-
ganelle attachment (Fig. 4, and data not shown). Clearly,
these TNF-induced parameters, hyperphosphorylation of
KLC, and inhibition of kinesin activity, exhibited the same
p38MAPK-dependence, indicating a functional relation-
ship between these phenomena.
Three members of the kinesin superfamily have been
implicated in transport of mitochondria, namely conven-
tional kinesin (KIF5B; Tanaka et al., 1998), KLP67A
(Pereira et al., 1997), and KIF1B (Nangaku et al., 1994). In
L929 cells, inhibition of conventional kinesin by SUK4
mAb resulted in perinuclear clustering of mitochondria
(Fig. 5, A and B; De Vos et al., 1998). This result indicates
conventional kinesin mediates plus end-directed transport
of mitochondria toward the cell periphery of L929 cells. In
agreement, conventional kinesin is associated with mito-
chondria in L929 cells, as shown by Western blot analysis
of purified mitochondria using anti-KIF5B Ab (Fig. 2 D).
Since SB203580 reversed the TNF-induced inhibition of
conventional kinesin in vitro, we verified whether inhibi-
tion of p38MAPK similarly could prevent TNF-induced
clustering of mitochondria in vivo. Indeed, while SB203580,
per se, did not influence the distribution of mitochondria
in L929 cells, SB203580 completely prevented TNF-induced
clustering of mitochondria (Fig. 6). Thus, both in vitro
results and results obtained in L929 cells show that
p38MAPK-dependent inhibition of conventional kinesin
by TNF is at the basis of impaired plus end-directed trans-
port of mitochondria and consequently clustering of mito-
chondria in L929 cells.
 
Discussion
 
In this study we investigated the involvement of the mo-
lecular motor kinesin in the previously described relocal-
ization of mitochondria from an evenly spread distribution
towards a perinuclear cluster, induced by TNF receptor-I
signal transduction in sensitive cell lines such as L929 (De
Vos et al., 1998). We provide data obtained in vitro and in
cultured cells showing that TNF inhibits conventional ki-
nesin in a p38MAPK-dependent way, likely by hyperphos-
phorylation of KLC. This inhibition arrested the motor
activity of the protein, but not its MT-binding or mito-
chondria-binding activities. This result provides a molecu-
lar basis for the observed clustering of the mitochondria in
L929 cells, namely repression of their plus end-directed
transport through inhibition of conventional kinesin.
Current models propose that soluble kinesin is kept in-
active in a folded conformation in which the KHC-tail:
KLC complex is adjacent to the motor domain. Upon
Figure 4. MT-gliding and
motility of mitochondria are
inhibited by SB203580. A
and B, L929 cells were left
untreated (CTRL), treated
with SB203580 (SB) or TNF
(TNF), or cotreated with
SB203580 and TNF (SB/
TNF). MAP-depleted cytosol
was prepared and the activity
of kinesin was tested in an
MT-gliding assay (A) and a
mitochondrial motility assay
(B). *Values are not signifi-
cantly different, as deter-
mined using a one-tailed het-
eroscedastic t test (P . 0.06).
C, The KHC and KLC con-
tent of the respective cytosols
used in the gliding and mito-
chondria motility assays was
verified by Western blot with
SUK4 mAb and antipan-
KLC Ab, respectively. Figure 5. Conventional kinesin transports mitochondria in L929
cells. A, L929 cells were left unloaded (CTRL), or were syringe-
loaded with irrelevant Ab (Irr.) or SUK4 mAb (SUK4). After
overnight recovery of the cells, the distribution of R123-stained
mitochondria was analyzed by CLSM in the cells that had taken
up Ab. The values shown represent the mean and SEM of four
randomly chosen microscopic fields each containing z40 loaded
cells. B, The SUK4 mAb-loaded cell typically shows a clustered
distribution of mitochondria. In contrast, the irrelevant Ab-
loaded cell retained the spread distribution of mitochondria. The
line indicates the cell periphery.
Figure 6. TNF-induced clus-
tering of mitochondria is in-
hibited by SB203580. The fre-
quency of cells exhibiting the
clustered mitochondrial phe-
notype was measured by
CLSM of R123-stained mito-
chondria 4 h after stimula-
tion. The values shown repre-
sent the mean and SEM of
four randomly chosen microscopic fields each containing z60
cells. *Values are not significantly different as determined using a
one-tailed heteroscedastic t test (P . 0.07).
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binding to its cargo, kinesin unfolds and becomes acti-
vated. However, while several authors clearly showed that
the KHC tail is involved in repression of KHC by folding
of the KHC molecule (Coy et al., 1999; Friedman and
Vale, 1999; Stock et al., 1999), the role of KLC in this fold-
ing-mediated repression of KHC is less clear. Although
most reports show a contribution of KLC, KLC are not es-
sential for folding-induced repression of KHC motility
(Coy et al., 1999; Friedman and Vale, 1999; Stock et al.,
1999). Moreover, other authors found that in KLC1-defi-
cient cells, conventional kinesin accumulates at its normal
site in the cell, although its activity is clearly inhibited
(Rahman et al., 1999). This observation suggests that in
absence of KLC, conventional kinesin can still bind to its
cargo, but lacks a subsequent activating event involving
KLC, which is consistent with our data showing that con-
ventional kinesin copurifies with mitochondria from both
untreated and TNF-treated cells, although its function is
clearly inhibited in the latter case.
Our results provide evidence that a kinase cascade trig-
gered by an extracellular stimulus, via the cytokine TNF,
directly phosphorylates KLC and, in this way, may regu-
late kinesin-mediated transport of organelles. Considering
the redundancy of kinase cascades triggered by various re-
ceptors in different cell types, it is likely that other extra-
cellular stimuli can similarly modulate kinesin-mediated
transport. However, depending on the cell type and its
physiological situation, this modulation may be achieved
through different mechanisms. Indeed, several reports
described phosphorylation as regulator of kinesin-medi-
ated transport in various cell systems. For example, in-
creased anterograde transport during nerve growth factor-
induced neurite outgrowth in PC12 cells is accompanied
by augmented KHC phosphorylation (Lee and Hollen-
beck, 1995). However, in this case it was speculated that
the increase in KHC phosphorylation promoted enhance-
ment of kinesin-mediated transport indirectly by shifting
kinesin from its soluble state toward organelle association.
We did not find any evidence supporting enhanced KHC
phosphorylation, nor a shift toward organelle association
and stimulation of organelle transport. Rather, our data
document a correlation between inhibition of organelle
transport and hyperphosphorylation of KLC without clear
interference with organelle attachment and MT-binding.
Thus, kinesin transport activity appears to be subject to
complex phosphorylation-dependent regulation. KHC phos-
phorylation controls binding to cargo (allows unfolding of
kinesin?), and p38MAPK-dependent KLC phosphoryla-
tion regulates the putative activation step upon binding to
cargo. This model is in agreement with observations made
in KLC1-deficient cells, which suggest that KLC are re-
quired for activation of kinesin when bound to its cargo
(Rahman et al., 1999). Although this scheme is tempting, it
might turn out to be an oversimplification. Indeed, hyper-
phosphorylation of a 79-kD KLC isoform enhances, in-
stead of inhibits, the activity of kinesin (Lindesmith et al.,
1997). However, in this study, phosphorylation of KLC
was induced in vitro by the phosphatase inhibitor OA,
whereas in our study, OA had no influence on TNF-
induced KLC phosphorylation (data not shown). Further-
more, like McIlvain et al. (1994), we did not find increased
KLC phosphorylation in OA-treated cells (data not shown).
As several phosphorylation sites are present in KLC
(Sato-Yoshitake et al., 1992), OA and TNF-signaling pos-
sibly induce KLC phosphorylation on other residues and
elicit in that way opposite effects. A differential involve-
ment of multiple KLC kinases may contribute to such an ef-
fect. Indeed, our observation that TNF-signaling induces
phosphorylation of two KLC isoforms, KLC1 and KLC2,
by activation of two isoform-specific kinases, whereas OA
induces phosphorylation of only one KLC isoform, likely
identical to KLC2, suggests that KLC1-specific kinase
could be the differential factor in the TNF-pathway. Ac-
cordingly, the difference between our observations and
those of others probably reflects the complexity and inter-
play of the regulatory pathways that control kinesin-medi-
ated transport. Additionally, (phosphorylation of) nonmo-
tor proteins such as MAPs were implicated in regulation
of organelle transport (Heins et al., 1991; Lopez and
Sheetz, 1993, 1995; Bulinski et al., 1997; Ebneth et al.,
1998). However, immunoinhibition of conventional kine-
sin in L929 cells in the absence of TNF induced clustering
of mitochondria similarly as observed in TNF-treated
L929 cells. This strongly indicates that, as in the case of
TNF treatment, repression of conventional kinesin is suffi-
cient to generate mitochondrial clustering without re-
quirement for other players. The vast knowledge on cyto-
kine signaling provides us with well-characterized tools for
future unraveling of the regulatory network governing or-
ganelle transport.
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